*By Brian Henry*
Even as British Prime Minister Theresa May suffered an embarrassing defeat as her Brexit vote was voted down in Parliament, and then only narrowly survived a no-confidence vote, investors remained relatively unrattled.
According to Chris Demetriou, the U.S. CEO at Aberdeen Standard Investments, the mild response to the vote was not a surprise.
"There are two elements to it," he told Cheddar Wednesday.
"The vote \[Tuesday\] and the no confidence vote \[Wednesday\] weren't really a surprise to anybody. It's long been speculated Theresa May didn't have the votes to carry the deal through Parliament."
Demetriou said that the decision by British lawmakers to reject the Brexit deal by such a historic margin ー 432 to 202 ーearlier this week actually has investors feeling confident.
"The resounding defeat, the size of the defeat, really suggests that a tweak to the deal probably isn't going to help get it through either. I think that, perhaps, is giving investors confidence that the can will be kicked down the road or potentially even a more formal withdrawal of Article 15."
"Investors want as a little change as possible in the current arrangement," he added.
Demetriou says productive trade talks between the U.S. and China as well as the Federal Reserve displaying patience on future rate hikes have led to less market volatility.
"A lot of the uncertainty we saw in the back end of the year, the escalation of trade discussions, perhaps concern around fed policy coming into 2019 ー a lot of that has reversed in the beginning of January."
But will the relative market peace last?
"There's a lot of positive news or certainly constructive news out there to offset some of the uncertainty that exists," Demetriou said.
"We do expect continued uncertainty, which breeds volatility in the markets and that will continue throughout the year."
For full interview [click here](https://cheddar.com/videos/the-uk-government-survives-no-confidence-vote-after-brexit-defeat).
President Donald Trump’s 2020 reelection campaign was powered by a cell phone app that allowed staff to monitor the movements of his millions of supporters, and offered intimate access to their social networks.
Rep. Chris Pappas is optimistic that President Donald Trump will sign the bipartisan Veterans COMPACT Act to provide mental health care and prevent veteran suicides.
the Trump administration’s unwillingness to begin steps to transition power to President-elect Joe Biden is preventing him from creating a national response, said Kathleen Sebelius, former United States Secretary of Health and Human Services under President Barack Obama.
President-elect Joe Biden on Monday said his administration would strengthen the country's vulnerable economy despite the exploding pandemic as he pushed forward with the business of preparing to assume the presidency.
President Donald Trump has hailed developments in the race for a vaccine for the resurgent coronavirus. He delivered his first public remarks Friday since his defeat by President-elect Joe Biden, even as he refuses to concede the election.
The reason for such calm is that Wall Street doesn't see Trump's anger, tweets or legal actions changing the results. And encouraging data about a potential COVID-19 vaccine has renewed investors' optimism even though virus cases are on the rise.
Just days following the presidential election, Twitter has stepped up its efforts to crackdown on misinformation, but questions are being raised about how marketers and users will interact with social media platforms going forward. Cheddar's Michelle Castillo reports.
New York's Lieutenant Governor, Kathy Hochul, joined Cheddar to discuss new state guidelines set to take effect as COVID-19 cases spike nationwide.
The report by Deutsche Bank proposed a 5% daily tax on each employee that continues to work from home.
California Rep. Ami Bera joined Cheddar to discuss what a transition to the Biden administration could look like for Americans in regards to the coronavirus pandemic. Bera also discusses how a Biden administration will tackle COVID-19 with science.
